Nomad Power Solutions, Inc. (NMAD): EPS (Diluted)
-$1.26
Year ended 2025-12-31
| Period ended | EPS (Diluted) | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | -$1.26 | n/m | 2026-03-31, From 2025-01-01 |
| 2024-12-31 | -$1.59 | n/m | 2026-03-31, From 2024-01-01 |
| 2023-12-31 | -$2.66 | n/m | 2025-03-24, From 2023-01-01 |
| 2022-12-31 | -$3.99 | n/a | 2024-03-19, From 2022-01-01 |
EPS (Diluted) at similar companies
| Company | Year ended | EPS (Diluted) | Change YoY |
|---|---|---|---|
| Nomad Power Solutions, Inc. (NMAD) | 2025-12-31 | -$1.26 | n/m |
| Propanc Biopharma, Inc. (PPCB) | 2026-06-30 | -$17.62 | n/m |
| Imunon, Inc. (IMNN) | 2025-12-31 | -$6.83 | n/m |
| Turn Therapeutics Inc. (TTRX) | 2025-12-31 | -$0.12 | n/m |
| Anebulo Pharmaceuticals, Inc. (ANEB) | 2025-06-30 | -$0.25 | n/m |
| PRF Technologies Ltd. (PRFX) | 2025-12-31 | -$7.47 | n/m |
| CalciMedica, Inc. (CALC) | 2025-12-31 | -$1.97 | n/m |
| Chemomab Therapeutics Ltd. (CMMB) | 2025-12-31 | $0.018 | -53.8% |
| CytoDyn Inc. (CYDY) | 2026-05-31 | -$0.03 | n/a |
Compare NMAD, PPCB, IMNN, TTRX side by side · Screen every company in Pharmaceutical Preparations ↗